Company and Stock Identity

How DeepHealth Connects to the Public Market

Company structure
Wholly owned subsidiary of RadNet
Market access
Public parent: RadNet, Nasdaq: RDNT.
Stock name
RadNet, Inc.
Ticker and exchange
Nasdaq: RDNT
Research focus
Use RadNet filings to measure the digital-health business, then use FDA and clinical sources to verify the claims attached to DeepHealth and acquired products.

DeepHealth is not separately traded. It is the digital health and AI business of RadNet.

Dated Market Snapshot

Oct 26, 2026

Last price
$70.05
Change
-0.41%
Previous close
$70.34
52-week high / low
$85.84/$50.82
Market cap
5,512,742,853

Automated from Nasdaq. Check the exchange or investor-relations page for the current price.

Open the public company market data feed for the full directory, ownership relationships, stock identifiers, and dated snapshots.

First-Hand Company News

Latest Developments

... RadNet ... Public parent source

DeepHealth announces two FDA clearances for its breast imaging suite

RadNet said DeepHealth received clearances for breast arterial calcification assessment and prior-exam integration in its breast imaging products.

Why it matters: One clearance adds a cardiovascular signal to a breast imaging visit. The other brings prior exams into the current reading. Both could make screening more useful, but the value depends on the FDA-cleared intended use, false-positive behavior, and how the tools fit into a radiologist's work.

See company developments across the healthcare AI market.

Careers and Qualifications

What to Know Before Applying

Work areas: Radiology AI, informatics, engineering, clinical science, regulatory affairs, product, implementation, and imaging operations.

Qualification signal: Imaging informatics, radiology workflow, clinical validation, or software medical-device experience is useful. Corporate roles may sit at DeepHealth or its RadNet parent.

Check current roles at DeepHealth. A careers page is the source of record for openings. This profile does not claim a role is open unless the company lists it now.

Related Healthcare AI Roles

Training to Compare

Buyer Snapshot

Best-fit buyer
Radiology leadership, pathology leadership, clinical informatics, imaging IT, patient safety, and procurement
Primary use case
Triage studies, flag findings, support image interpretation, and coordinate time-sensitive care
Typical deployment
Usually integrated with PACS, RIS, worklists, or digital pathology systems and monitored inside the clinical workflow

Evidence questions

  • Was the tool tested prospectively and independently on comparable equipment and patients?
  • What are sensitivity, specificity, false positive workload, and time-to-action effects?
  • How does performance vary by site, scanner, demographic subgroup, and disease prevalence?

Regulatory and workflow questions

  • Which FDA authorization covers the exact product version, modality, and intended use?
  • Who retains final clinical responsibility and how is disagreement with the AI handled?
  • What post-deployment monitoring and material update notification does the vendor provide?

Data and contract questions

  • Where are images and derived data processed and retained?
  • Which PACS, RIS, pathology, and EHR integrations are supported in production?
  • Can data be used for model improvement, and what controls govern secondary use?

Evidence and Regulation

FDA Clearances on Record

DeepHealth appears on 10 cleared products in the federal 510(k) record, across 2 device types.

A clearance means the FDA agreed the product is close enough to something already on the market to be sold for that use. It is not a finding that the product helps patients, and it is not a ranking against anything else on this page. A company is linked to an FDA clearance only when the 510(k) applicant name on the government record is confirmed by hand to be that same company, including former corporate names. Name similarity alone is never enough, and rejected matches are listed below with the reason.

What the Published Research Says About This Work

Independent studies on the work itself help separate category evidence from one company's claims.

First-Hand Sources